Clinical Application of Adipose Derived Stem Cells for the Treatment of Aseptic Non-Unions: Current Stage and Future Perspectives-Systematic Review

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Mar 25

PMID 35328476

Authors

Amarildo Smakaj

Domenico De Mauro

Giuseppe Rovere

Silvia Pietramala

Giulio Maccauro

Ornella Parolini

Wanda Lattanzi

Francesco Liuzza

Affiliations

Soon will be listed here.

Abstract

Fracture non-union is a challenging orthopaedic issue and a socio-economic global burden. Several biological therapies have been introduced to improve traditional surgical approaches. Among these, the latest research has been focusing on adipose tissue as a powerful source of mesenchymal stromal cells, namely, adipose-derived stem cells (ADSCs). ADSC are commonly isolated from the stromal vascular fraction (SVF) of liposuctioned hypodermal adipose tissue, and their applications have been widely investigated in many fields, including non-union fractures among musculoskeletal disorders. This review aims at providing a comprehensive update of the literature on clinical application of ADSCs for the treatment of non-unions in humans. The study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Only three articles met our inclusion criteria, with a total of 12 cases analyzed for demographics and harvesting, potential manufacturing and implantation of ADSCs. The review of the literature suggests that adipose derived cell therapy can represent a promising alternative in bone regenerative medicine for the enhancement of non-unions and bone defects. The low number of manuscripts reporting ADSC-based therapies for long bone fracture healing suggests some critical issues that are discussed in this review. Nevertheless, further investigations on human ADSC therapies are needed to improve the knowledge on their translational potential and to possibly achieve a consensus on their use for such applications.

Citing Articles

Mesenchymal stem cells therapy for the treatment of non-union fractures: a systematic review and meta-analysis.

Cui C, Lin F, Xia L, Zhang X BMC Musculoskelet Disord. 2025; 26(1):245.

PMID: 40069694 PMC: 11900535. DOI: 10.1186/s12891-025-08365-w.

Recent advances in the management of knee osteoarthritis: a narrative review.

Shtroblia V, Petakh P, Kamyshna I, Halabitska I, Kamyshnyi O Front Med (Lausanne). 2025; 12:1523027.

PMID: 39906596 PMC: 11790583. DOI: 10.3389/fmed.2025.1523027.

Optimization and Implication of Adipose-Derived Stem Cells in Craniofacial Bone Regeneration and Repair.

Gu C, Tang Q, Li L, Chen Y Bioengineering (Basel). 2024; 11(11).

PMID: 39593759 PMC: 11592193. DOI: 10.3390/bioengineering11111100.

Hemiarthroplasty vs. internal fixation for nondisplaced femoral neck fracture in mainland China: a cost-effectiveness analysis.

Wang S, Tan L, Sheng B Front Surg. 2024; 11:1437290.

PMID: 39268494 PMC: 11391527. DOI: 10.3389/fsurg.2024.1437290.

Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma.

Gladys A, Mazurski A, Czekaj P Int J Mol Sci. 2024; 25(14).

PMID: 39063048 PMC: 11277008. DOI: 10.3390/ijms25147806.

References

Di Taranto G, Cicione C, Visconti G, Isgro M, Barba M, Di Stasio E . Qualitative and quantitative differences of adipose-derived stromal cells from superficial and deep subcutaneous lipoaspirates: a matter of fat. Cytotherapy. 2015; 17(8):1076-89. DOI: 10.1016/j.jcyt.2015.04.004. View

Schmal H, Brix M, Bue M, Ekman A, Ferreira N, Gottlieb H . Nonunion - consensus from the 4th annual meeting of the Danish Orthopaedic Trauma Society. EFORT Open Rev. 2020; 5(1):46-57. PMC: 7017598. DOI: 10.1302/2058-5241.5.190037. View

Filardo G, Perdisa F, Roffi A, Marcacci M, Kon E . Stem cells in articular cartilage regeneration. J Orthop Surg Res. 2016; 11:42. PMC: 4830073. DOI: 10.1186/s13018-016-0378-x. View

Fernandez De Grado G, Keller L, Idoux-Gillet Y, Wagner Q, Musset A, Benkirane-Jessel N . Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018; 9:2041731418776819. PMC: 5990883. DOI: 10.1177/2041731418776819. View

Mizuno H . Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch. 2009; 76(2):56-66. DOI: 10.1272/jnms.76.56. View

Yoon E, Dhar S, Chun D, Gharibjanian N, Evans G . In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng. 2007; 13(3):619-27. DOI: 10.1089/ten.2006.0102. View

Hak D, Fitzpatrick D, Bishop J, Marsh J, Tilp S, Schnettler R . Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. Injury. 2014; 45 Suppl 2:S3-7. DOI: 10.1016/j.injury.2014.04.002. View

Samavedi S, Whittington A, Goldstein A . Calcium phosphate ceramics in bone tissue engineering: a review of properties and their influence on cell behavior. Acta Biomater. 2013; 9(9):8037-45. DOI: 10.1016/j.actbio.2013.06.014. View

Galvez-Sirvent E, Ibarzabal-Gil A, Rodriguez-Merchan E . Treatment options for aseptic tibial diaphyseal nonunion: A review of selected studies. EFORT Open Rev. 2020; 5(11):835-844. PMC: 7722944. DOI: 10.1302/2058-5241.5.190077. View

10.

Saulnier N, Lattanzi W, Puglisi M, Pani G, Barba M, Piscaglia A . Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. Eur Rev Med Pharmacol Sci. 2009; 13 Suppl 1:71-8. View

11.

Cicione C, Di Taranto G, Barba M, Isgro M, DAlessio A, Cervelli D . In Vitro Validation of a Closed Device Enabling the Purification of the Fluid Portion of Liposuction Aspirates. Plast Reconstr Surg. 2016; 137(4):1157-1167. DOI: 10.1097/PRS.0000000000002014. View

12.

Giannoudis P, Einhorn T, Marsh D . Fracture healing: the diamond concept. Injury. 2008; 38 Suppl 4:S3-6. DOI: 10.1016/s0020-1383(08)70003-2. View

13.

Barba M, Di Taranto G, Lattanzi W . Adipose-derived stem cell therapies for bone regeneration. Expert Opin Biol Ther. 2017; 17(6):677-689. DOI: 10.1080/14712598.2017.1315403. View

14.

Dufrane D, Docquier P, Delloye C, Poirel H, Andre W, Aouassar N . Scaffold-free Three-dimensional Graft From Autologous Adipose-derived Stem Cells for Large Bone Defect Reconstruction: Clinical Proof of Concept. Medicine (Baltimore). 2015; 94(50):e2220. PMC: 5058905. DOI: 10.1097/MD.0000000000002220. View

15.

Song J, Kim Y, Kweon O, Kang B . Use of stem-cell sheets expressing bone morphogenetic protein-7 in the management of a nonunion radial fracture in a Toy Poodle. J Vet Sci. 2017; 18(4):555-558. PMC: 5746451. DOI: 10.4142/jvs.2017.18.4.555. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

17.

Zhang J, Liu Y, Chen Y, Yuan L, Liu H, Wang J . Adipose-Derived Stem Cells: Current Applications and Future Directions in the Regeneration of Multiple Tissues. Stem Cells Int. 2021; 2020:8810813. PMC: 7787857. DOI: 10.1155/2020/8810813. View

18.

Zura R, Xiong Z, Einhorn T, Watson J, Ostrum R, Prayson M . Epidemiology of Fracture Nonunion in 18 Human Bones. JAMA Surg. 2016; 151(11):e162775. DOI: 10.1001/jamasurg.2016.2775. View

19.

Nauth A, Lee M, Gardner M, Brinker M, Warner S, Tornetta 3rd P . Principles of Nonunion Management: State of the Art. J Orthop Trauma. 2018; 32 Suppl 1:S52-S57. DOI: 10.1097/BOT.0000000000001122. View

20.

Veriter S, Andre W, Aouassar N, Poirel H, Lafosse A, Docquier P . Human Adipose-Derived Mesenchymal Stem Cells in Cell Therapy: Safety and Feasibility in Different "Hospital Exemption" Clinical Applications. PLoS One. 2015; 10(10):e0139566. PMC: 4615620. DOI: 10.1371/journal.pone.0139566. View